Arzneimittel zur Behandlung dieser Krankheit. Zum anderen wurde auch der Mangel wirksamer Medikamente gegen vernachlässigte … Immatrialgüterrechte wesentliche Vorraussetzung für die konstante Entwicklung innovativer Arzneimittel seien. Kritiker des TRIPS … Arzneimittel gegen vernachlässigte Krankheiten bis zum 30.06.2008 überprüft. Unter Berücksichtigung des kurzfristigen …

% vaccination coverage will be probable; hence, the need for vaccination strategies that will have the greatest reduction on the …-biased vaccination strategies: one model incorporates temporal demographics (i.e., age) in population compartments; the other non …

practice and vaccination costs in Australia. This thesis describes cost-effectiveness of two selected immunisation … interventions in Australia: influenza and hepatitis B. The cost-effectiveness of reducing the influenza vaccination age threshold to … 50 from the current 65 was analysed first. Next, the cost-effectiveness of universal hepatitis B infant vaccination …

-like pattern of the pandemic and consider the impact of the rate of vaccination and the strength of non-pharmaceutical intervention … measures on the probability of emergence of a resistant strain. As expected, we found that a fast rate of vaccination decreases … end of the vaccination campaign can substantially reduce the probability of resistant strain establishment. These results …

). India’s accession to the World Trade Organization’s (WTO) agreement on Trade Related Aspects of Intellectual Property Rights … products is still very young and India has yet to develop a new to the world innovation in this field. To fulfill their global …

pharmaceuticals- biotechnologysectors. It is built on the premise that ceteris paribus participation of Indian firms in IPcreation and …